BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6506387)

  • 1. [Intravesical chemotherapy of bladder cancer using adriamycin].
    Matveev BP; Shipilov VI; Romanov VA; Minakova LR; Gorilovskiĭ LM
    Urol Nefrol (Mosk); 1984; (5):6-9. PubMed ID: 6506387
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of bladder cancer: current status and prospects.
    Smith WK; Koontz WW
    Va Med; 1979 Feb; 106(2):131-4. PubMed ID: 425674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of azauridine in cancer of the urinary bladder].
    Erukhimov LS; Vermel' EM
    Vopr Onkol; 1969; 15(5):91. PubMed ID: 5360151
    [No Abstract]   [Full Text] [Related]  

  • 5. What therapeutic approach should be adopted for superficial bladder tumours?
    Chatelain C
    Prog Clin Biol Res; 1984; 162B():211-8. PubMed ID: 6504896
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
    Rodriguez LH; Johnson DE; Holoye PY; Samuels ML
    Cancer Treat Rep; 1977; 61(1):87-8. PubMed ID: 324624
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathological changes associated with topical chemotherapy of adriamycin for bladder cancer].
    Fujioka T; Ishii N; Chiba R
    Hinyokika Kiyo; 1983 Aug; 29(8):869-73. PubMed ID: 6675437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). IV].
    Ogawa H
    Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):746-55. PubMed ID: 5388929
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy with adriamycin and 5-fluorouracil in advanced bladder carcinoma.
    Veronesi A; Magri MD; Figoli F; Tirelli U; Galligioni E; Trovò MG; Merlo A; Dal Bò V; Tumolo S; Grigoletto E
    Clin Oncol; 1982 Jun; 8(2):103-6. PubMed ID: 7105520
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of bladder cancer: current progress.
    Murphy GP
    N Y State J Med; 1977 Oct; 77(12):1889-95. PubMed ID: 270015
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). 3].
    Ogawa H
    Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):728-45. PubMed ID: 5388928
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].
    Takahashi Y; Yamamoto N; Deguchi T; Kuriyama M; Yoh M; Yasuda M; Nakano M; Kawada Y; Takeuchi T; Shinoda I
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1310-3. PubMed ID: 9703815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adriamycin and epirubicin in superficial bladder cancer and carcinoma in situ.
    da Silva FC
    Prog Clin Biol Res; 1989; 303():401-10. PubMed ID: 2675001
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL; Ojea A; Jamardo D; Figueiredo L
    Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
    Sulkes A; Fuks Z
    Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional intra-arterial infusion of adriamycin in the treatment of cancer.
    Kraybill WG; Harrison M; Sasaki T; Fletcher WS
    Surg Gynecol Obstet; 1977 Mar; 144(3):335-8. PubMed ID: 190716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravesical chemotherapy with 4'-Epi-Adriamycin in patients with superficial bladder tumors].
    Tsushima T; Matsumura Y; Ozaki Y; Yoshimoto J; Obama T; Akagi T; Nasu Y; Ohmori H
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2502-5. PubMed ID: 6594972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.